Annual Interest Expense
$13.43 M
+$1.86 M+16.08%
31 December 2023
Summary:
Core Laboratories NV annual interest expense is currently $13.43 million, with the most recent change of +$1.86 million (+16.08%) on 31 December 2023. During the last 3 years, it has fallen by -$942.00 thousand (-6.55%). CLB annual interest expense is now -37.85% below its all-time high of $21.61 million, reached on 31 December 2008.CLB Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$3.11 M
-$101.00 K-3.15%
30 September 2024
Summary:
Core Laboratories NV quarterly interest expense is currently $3.11 million, with the most recent change of -$101.00 thousand (-3.15%) on 30 September 2024. Over the past year, it has dropped by -$39.00 thousand (-1.24%). CLB quarterly interest expense is now -61.15% below its all-time high of $8.00 million, reached on 30 June 2008.CLB Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$13.36 M
-$39.00 K-0.29%
30 September 2024
Summary:
Core Laboratories NV TTM interest expense is currently $13.36 million, with the most recent change of -$39.00 thousand (-0.29%) on 30 September 2024. Over the past year, it has increased by +$465.00 thousand (+3.61%). CLB TTM interest expense is now -17.42% below its all-time high of $16.18 million, reached on 30 September 2010.CLB TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.1% | -1.2% | +3.6% |
| 3 y3 years | -6.5% | +16.4% | +40.9% |
| 5 y5 years | +0.8% | -15.1% | -9.3% |
CLB Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.5% | +46.7% | -14.1% | +20.0% | -0.5% | +46.0% |
| 5 y | 5 years | -8.6% | +46.7% | -33.5% | +128.0% | -11.2% | +46.0% |
| alltime | all time | -37.9% | +52.3% | -61.1% | +128.0% | -17.4% | +179.3% |
Core Laboratories NV Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.11 M(-3.1%) | $13.36 M(-0.3%) |
| June 2024 | - | $3.21 M(-6.3%) | $13.40 M(-0.2%) |
| Mar 2024 | - | $3.42 M(-5.4%) | $13.42 M(-0.0%) |
| Dec 2023 | $13.43 M(+16.1%) | $3.62 M(+15.0%) | $13.43 M(+4.2%) |
| Sept 2023 | - | $3.15 M(-2.8%) | $12.89 M(+0.1%) |
| June 2023 | - | $3.24 M(-5.6%) | $12.88 M(+4.3%) |
| Mar 2023 | - | $3.43 M(+11.3%) | $12.36 M(+6.8%) |
| Dec 2022 | $11.57 M(+26.4%) | $3.08 M(-1.8%) | $11.57 M(+4.4%) |
| Sept 2022 | - | $3.14 M(+15.9%) | $11.08 M(+4.4%) |
| June 2022 | - | $2.71 M(+2.4%) | $10.61 M(+1.7%) |
| Mar 2022 | - | $2.64 M(+2.1%) | $10.43 M(+14.0%) |
| Dec 2021 | $9.15 M(-36.3%) | $2.59 M(-3.0%) | $9.15 M(-3.5%) |
| Sept 2021 | - | $2.67 M(+5.5%) | $9.48 M(-17.4%) |
| June 2021 | - | $2.53 M(+85.6%) | $11.48 M(-6.8%) |
| Mar 2021 | - | $1.36 M(-53.3%) | $12.32 M(-14.2%) |
| Dec 2020 | $14.37 M(-2.2%) | $2.92 M(-37.5%) | $14.37 M(-4.4%) |
| Sept 2020 | - | $4.67 M(+38.7%) | $15.04 M(+7.2%) |
| June 2020 | - | $3.37 M(-1.2%) | $14.03 M(-2.4%) |
| Mar 2020 | - | $3.41 M(-4.9%) | $14.38 M(-2.1%) |
| Dec 2019 | $14.69 M(+10.2%) | $3.59 M(-2.0%) | $14.69 M(-0.3%) |
| Sept 2019 | - | $3.66 M(-1.4%) | $14.74 M(+2.7%) |
| June 2019 | - | $3.71 M(-0.3%) | $14.35 M(+3.0%) |
| Mar 2019 | - | $3.73 M(+2.5%) | $13.93 M(+4.5%) |
| Dec 2018 | $13.33 M(+24.2%) | $3.63 M(+10.9%) | $13.33 M(+7.4%) |
| Sept 2018 | - | $3.28 M(-0.5%) | $12.41 M(+4.8%) |
| June 2018 | - | $3.30 M(+5.6%) | $11.84 M(+5.4%) |
| Mar 2018 | - | $3.12 M(+14.8%) | $11.24 M(+4.7%) |
| Dec 2017 | $10.73 M(-7.2%) | $2.72 M(+0.4%) | $10.73 M(+1.6%) |
| Sept 2017 | - | $2.71 M(+0.6%) | $10.56 M(+1.3%) |
| June 2017 | - | $2.69 M(+2.8%) | $10.43 M(-3.1%) |
| Mar 2017 | - | $2.62 M(+2.7%) | $10.76 M(-7.1%) |
| Dec 2016 | $11.57 M | $2.55 M(-0.8%) | $11.57 M(-6.8%) |
| Sept 2016 | - | $2.57 M(-15.0%) | $12.41 M(-6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $3.02 M(-12.0%) | $13.32 M(-0.7%) |
| Mar 2016 | - | $3.43 M(+1.3%) | $13.41 M(+8.3%) |
| Dec 2015 | $12.38 M(+16.8%) | $3.39 M(-2.3%) | $12.38 M(+4.3%) |
| Sept 2015 | - | $3.47 M(+11.4%) | $11.87 M(+8.3%) |
| June 2015 | - | $3.12 M(+29.7%) | $10.96 M(+3.0%) |
| Mar 2015 | - | $2.40 M(-16.6%) | $10.64 M(+0.4%) |
| Dec 2014 | $10.60 M(+13.8%) | $2.88 M(+12.5%) | $10.60 M(+3.9%) |
| Sept 2014 | - | $2.56 M(-8.3%) | $10.20 M(+2.6%) |
| June 2014 | - | $2.79 M(+18.2%) | $9.94 M(+5.6%) |
| Mar 2014 | - | $2.36 M(-4.8%) | $9.41 M(+1.0%) |
| Dec 2013 | $9.32 M(+5.6%) | $2.48 M(+7.9%) | $9.32 M(+2.1%) |
| Sept 2013 | - | $2.30 M(+1.7%) | $9.13 M(+1.6%) |
| June 2013 | - | $2.26 M(-0.3%) | $8.98 M(+1.0%) |
| Mar 2013 | - | $2.27 M(-1.0%) | $8.90 M(+0.9%) |
| Dec 2012 | $8.82 M(-19.1%) | $2.29 M(+6.1%) | $8.82 M(+0.9%) |
| Sept 2012 | - | $2.16 M(-0.8%) | $8.74 M(-16.0%) |
| June 2012 | - | $2.18 M(-0.5%) | $10.41 M(-3.0%) |
| Mar 2012 | - | $2.19 M(-1.2%) | $10.73 M(-1.6%) |
| Dec 2011 | $10.90 M(-31.2%) | $2.22 M(-42.1%) | $10.90 M(-11.6%) |
| Sept 2011 | - | $3.83 M(+53.1%) | $12.34 M(-1.5%) |
| June 2011 | - | $2.50 M(+5.9%) | $12.53 M(-11.4%) |
| Mar 2011 | - | $2.36 M(-35.4%) | $14.14 M(-10.7%) |
| Dec 2010 | $15.84 M(+2.0%) | $3.65 M(-9.1%) | $15.84 M(-2.1%) |
| Sept 2010 | - | $4.01 M(-2.4%) | $16.18 M(+0.7%) |
| June 2010 | - | $4.11 M(+1.4%) | $16.06 M(+1.7%) |
| Mar 2010 | - | $4.06 M(+1.8%) | $15.78 M(+1.7%) |
| Dec 2009 | $15.52 M(-28.2%) | $3.99 M(+2.4%) | $15.52 M(+34.6%) |
| Sept 2009 | - | $3.90 M(+1.4%) | $11.54 M(+51.0%) |
| June 2009 | - | $3.84 M(+1.1%) | $7.64 M(-35.3%) |
| Mar 2009 | - | $3.80 M(-52.5%) | $11.80 M(-7.7%) |
| Dec 2008 | $21.61 M | - | - |
| June 2008 | - | $8.00 M(+67.3%) | $12.78 M(+167.3%) |
| Mar 2008 | - | $4.78 M | $4.78 M |
FAQ
- What is Core Laboratories NV annual interest expense?
- What is the all time high annual interest expense for Core Laboratories NV?
- What is Core Laboratories NV annual interest expense year-on-year change?
- What is Core Laboratories NV quarterly interest expense?
- What is the all time high quarterly interest expense for Core Laboratories NV?
- What is Core Laboratories NV quarterly interest expense year-on-year change?
- What is Core Laboratories NV TTM interest expense?
- What is the all time high TTM interest expense for Core Laboratories NV?
- What is Core Laboratories NV TTM interest expense year-on-year change?
What is Core Laboratories NV annual interest expense?
The current annual interest expense of CLB is $13.43 M
What is the all time high annual interest expense for Core Laboratories NV?
Core Laboratories NV all-time high annual interest expense is $21.61 M
What is Core Laboratories NV annual interest expense year-on-year change?
Over the past year, CLB annual interest expense has changed by +$1.86 M (+16.08%)
What is Core Laboratories NV quarterly interest expense?
The current quarterly interest expense of CLB is $3.11 M
What is the all time high quarterly interest expense for Core Laboratories NV?
Core Laboratories NV all-time high quarterly interest expense is $8.00 M
What is Core Laboratories NV quarterly interest expense year-on-year change?
Over the past year, CLB quarterly interest expense has changed by -$39.00 K (-1.24%)
What is Core Laboratories NV TTM interest expense?
The current TTM interest expense of CLB is $13.36 M
What is the all time high TTM interest expense for Core Laboratories NV?
Core Laboratories NV all-time high TTM interest expense is $16.18 M
What is Core Laboratories NV TTM interest expense year-on-year change?
Over the past year, CLB TTM interest expense has changed by +$465.00 K (+3.61%)